{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T11:38:40Z","timestamp":1779363520000,"version":"3.53.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T00:00:00Z","timestamp":1702425600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2016A030313228"],"award-info":[{"award-number":["2016A030313228"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671182"],"award-info":[{"award-number":["81671182"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002402","name":"Sun Yat-sen University","doi-asserted-by":"publisher","award":["[2021]02\u2013123\u201301"],"award-info":[{"award-number":["[2021]02\u2013123\u201301"]}],"id":[{"id":"10.13039\/501100002402","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jgar.2023.12.009","type":"journal-article","created":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T21:35:53Z","timestamp":1703194553000},"page":"167-174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Analysis of the relationship between drug susceptibility of Cryptococcus neoformans isolates and mortality in HIV-negative cryptococcal meningitis"],"prefix":"10.1016","volume":"36","author":[{"given":"Zhihui","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3042-1837","authenticated-orcid":false,"given":"Zirong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dasen","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuhua","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2023.12.009_bib0001","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2022.942506","article-title":"Analysis of the efficacy and related factors of ventriculoperitoneal shunt for AIDS with cryptococcal meningitis","volume":"9","author":"Chai","year":"2022","journal-title":"Front Surg"},{"key":"10.1016\/j.jgar.2023.12.009_bib0002","article-title":"Molecular epidemiology and antifungal resistance of Cryptococcus neoformans from human immunodeficiency virus-negative and human immunodeficiency virus-positive patients in Eastern China","volume":"13","author":"Zhou","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgar.2023.12.009_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.723251","article-title":"High prevalence of HIV-related cryptococcosis and increased resistance to fluconazole of the Cryptococcus neoformans Complex in Jiangxi Province. South Central China","volume":"11","author":"Yang","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jgar.2023.12.009_bib0004","first-page":"61","article-title":"Cryptococcal infections in non-HIV-infected patients","volume":"124","author":"Pappas","year":"2013","journal-title":"Trans Am Clin 363 Climatol Assoc"},{"key":"10.1016\/j.jgar.2023.12.009_bib0005","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.idc.2015.10.006","article-title":"Cryptococcosis","volume":"30","author":"Maziarz","year":"2016","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.jgar.2023.12.009_bib0006","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/mmi.14565","article-title":"Combatting the evolution of antifungal resistance in Cryptococcus neoformans","volume":"114","author":"Bermas","year":"2020","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.jgar.2023.12.009_bib0007","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1056\/NEJM198708063170602","article-title":"Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks","volume":"317","author":"Dismukes","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgar.2023.12.009_bib0008","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00069-19","article-title":"Antifungal susceptibility testing: current approaches","volume":"33","author":"Berkow","year":"2020","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jgar.2023.12.009_bib0009","doi-asserted-by":"crossref","unstructured":"EUCAST. 2008. EUCAST technical note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds. doi:10.1111\/j.1469-0691.2008.02086.x.","DOI":"10.1111\/j.1469-0691.2008.02086.x"},{"key":"10.1016\/j.jgar.2023.12.009_bib0010","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1439-0507.2006.01293.x","article-title":"Antifungal drug susceptibility of Cryptococcus neoformans from clinical sources in Nairobi, Kenya","volume":"50","author":"Bii","year":"2007","journal-title":"Mycoses"},{"key":"10.1016\/j.jgar.2023.12.009_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.bjid.2019.11.004","article-title":"Clinical and microbiological characteristics of cryptococcosis at an university hospital in China from 2013 to 2017","volume":"24","author":"Fang","year":"2020","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.jgar.2023.12.009_bib0012","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1128\/JCM.00393-11","article-title":"Quality control guidelines for amphotericin B, Itraconazole, posaconazole, and voriconazole disk diffusion susceptibility tests with nonsupplemented Mueller-Hinton Agar (CLSI M51-A document) for nondermatophyte Filamentous Fungi","volume":"49","author":"Espinel-Ingroff","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2023.12.009_bib0013","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1128\/JCM.00248-12","article-title":"Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution","volume":"50","author":"Pfaller","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2023.12.009_bib0014","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2023.12.009_bib0015","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1128\/JCM.01130-12","article-title":"In vitro susceptibilities of yeast species to fluconazole and voriconazole as determined by the 2010 National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study","volume":"50","author":"Wang","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2023.12.009_bib0016","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/myc.12171","article-title":"Molecular epidemiology and antifungal susceptibility of Serbian Cryptococcus neoformans isolates","volume":"57","author":"Arsic Arsenijevic","year":"2014","journal-title":"Mycoses"},{"key":"10.1016\/j.jgar.2023.12.009_bib0017","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1086\/593194","article-title":"Dose response effect of high-dose fluconazole for HIV-associated cryptococcal meningitis in southwestern Uganda","volume":"47","author":"Longley","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2023.12.009_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0267842","article-title":"Clinical epidemiology and high genetic diversity amongst Cryptococcus Spp. isolates infecting people living with HIV in Kinshasa, Democratic Republic of Congo","volume":"17","author":"Bive","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2023.12.009_bib0019","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/myc.12863","article-title":"Genotypic diversity and antifungal susceptibility of Cryptococcus neoformans isolates from paediatric patients in China","volume":"62","author":"Hong","year":"2019","journal-title":"Mycoses"},{"key":"10.1016\/j.jgar.2023.12.009_bib0020","doi-asserted-by":"crossref","DOI":"10.1007\/s11033-021-06433-7","article-title":"Genotypic diversity of Iranian Cryptococcus neoformans using multilocus sequence typing (MLST) and susceptibility to antifungals","volume":"48","author":"Moslem","year":"2021","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.jgar.2023.12.009_bib0021","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3390\/jof7040282","article-title":"Cryptococcus neoformans and Cryptococcus gattii species complexes in Latin America: a map of molecular types, genotypic diversity, and antifungal susceptibility as reported by the Latin American Cryptococcal Study Group","volume":"7","author":"Firacative","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.jgar.2023.12.009_bib0022","article-title":"Minimum inhibitory concentration distribution of fluconazole against Cryptococcus species and the fluconazole exposure prediction model","volume":"6","author":"Chesdachai","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jgar.2023.12.009_bib0023","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s10096-020-04013-4","article-title":"Molecular epidemiology and antifungal susceptibilities of Cryptococcus species isolates from HIV and non-HIV patients in Southwest China","volume":"40","author":"Wu","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2023.12.009_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060431","article-title":"Predictors of mortality and differences in clinical features among patients with Cryptococcosis according to immune status","volume":"8","author":"Brizendine","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2023.12.009_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/a94bc542-6682-4579-a315-57019cef7e0e","article-title":"Comparison and temporal trends of three groups with cryptococcosis: HIV-infected, solid organ transplant, and HIV-negative\/non-transplant","volume":"7","author":"Bratton","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2023.12.009_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2022.105521","article-title":"A holistic review on Cryptococcus neoformans","volume":"166","author":"Rathore","year":"2022","journal-title":"Microb Pathog"},{"key":"10.1016\/j.jgar.2023.12.009_bib0027","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa1544","article-title":"Antifungal susceptibility does not correlate with fungal clearance or survival in AIDS-associated cryptococcal meningitis","volume":"73","author":"O\u2019Connor","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2023.12.009_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008137","article-title":"Decreasing fluconazole susceptibility of clinical South African Cryptococcus neoformans isolates over a decade","volume":"14","author":"Naicker","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jgar.2023.12.009_bib0029","doi-asserted-by":"crossref","first-page":"e02108","DOI":"10.1128\/AAC.02108-16","article-title":"Physiological differences in Cryptococcus neoformans strains in vitro versus in vivo and their effects on antifungal susceptibility","volume":"61","author":"Grossman","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2023.12.009_bib0030","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJMoa1710922","article-title":"Antifungal combinations for treatment of cryptococcal meningitis in Africa","volume":"378","author":"Molloy","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgar.2023.12.009_bib0031","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/cid\/cir745","article-title":"Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis","volume":"54","author":"Loyse","year":"2012","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716523002163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716523002163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:03:10Z","timestamp":1761991390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716523002163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":31,"alternative-id":["S2213716523002163"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2023.12.009","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of the relationship between drug susceptibility of Cryptococcus neoformans isolates and mortality in HIV-negative cryptococcal meningitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2023.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}